- Home
- ACET vs LSF Comparison
ACET vs LSF Comparison
Compare ACET & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACET | LSF |
|---|---|---|
| Founded | 1947 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.6M | 23.8M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ACET | LSF |
|---|---|---|
| Price | $7.01 | $2.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $65.33 | $12.00 |
| AVG Volume (30 Days) | ★ 174.7K | 64.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 59.82 | ★ 75.28 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $43,295,137.00 |
| Revenue This Year | N/A | $15.87 |
| Revenue Next Year | N/A | $14.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 26.50 |
| 52 Week Low | $0.45 | $1.98 |
| 52 Week High | $9.05 | $7.94 |
Technical Indicators
Market Signals| Indicator | ACET | LSF |
|---|---|---|
| Relative Strength Index (RSI) | 48.89 | 40.75 |
| Support Level | $0.62 | $2.46 |
| Resistance Level | $8.46 | $2.76 |
| Average True Range (ATR) | 0.53 | 0.22 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 50.43 | 19.35 |
Price Performance
Historical ComparisonAbout ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.